Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manasi Das

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|January 26, 2021
Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse modelsManasi Das, Lesley G Ellies, Deepak Kumar, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2026
Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitorsYunpeng Yang, Tyler Mandt, David Mittelstein, et al.
The Journal of Clinical Investigation|August 9, 2019
Degradation of splicing factor SRSF3 contributes to progressive liver diseaseDeepak Kumar, Manasi Das, Consuelo Sauceda, et al.
Oncotarget|October 8, 2016
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, Manasi Das, et al.
Hepatology (Baltimore, Md.)|March 8, 2024
Restoring SRSF3 in Kupffer cells attenuates obesity-related insulin resistanceHong Gao, Karina C E Rocha, Zhongmou Jin, et al.
Diabetes|May 31, 2023
Loss of cAMP Signaling in CD11c Immune Cells Protects Against Diet-Induced ObesityLiping Zeng, D Scott Herdman, Sung Min Lee, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Nature Communications|January 26, 2021
Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse modelsManasi Das, Lesley G Ellies, Deepak Kumar, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2026
Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitorsYunpeng Yang, Tyler Mandt, David Mittelstein, et al.
The Journal of Clinical Investigation|August 9, 2019
Degradation of splicing factor SRSF3 contributes to progressive liver diseaseDeepak Kumar, Manasi Das, Consuelo Sauceda, et al.
Oncotarget|October 8, 2016
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, Manasi Das, et al.
Hepatology (Baltimore, Md.)|March 8, 2024
Restoring SRSF3 in Kupffer cells attenuates obesity-related insulin resistanceHong Gao, Karina C E Rocha, Zhongmou Jin, et al.
Diabetes|May 31, 2023
Loss of cAMP Signaling in CD11c Immune Cells Protects Against Diet-Induced ObesityLiping Zeng, D Scott Herdman, Sung Min Lee, et al.
Pageof 3